The Non-viral Drug Delivery Systems Market To Grow Owing To Increasing Advantages Over Viral Delivery Methods

By Author: colin
Total Articles: 166
Comment this article

The non-viral drug delivery systems market involves the development and use of delivery platforms such as targeted nanoparticles, polymeric micelles, liposomes, and other nanocarriers to efficiently deliver therapeutic payloads including drugs, genes, and proteins to specific locations in the body. These systems provide various advantages over traditional delivery methods such as improved efficacy, reduced toxicity to healthy tissues, and ability to deliver both hydrophilic and hydrophobic drug molecules. The non-viral systems overcome many limitations of viral vectors and have emerged as a safe and cost-effective alternative for drug and gene delivery applications.

The Non-Viral Drug Delivery Systems Market is estimated to be valued at US$ 8.1 Bn in 2024 and is expected to exhibit a CAGR of 13.% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the non-viral drug delivery systems are Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, eTheRNA Immunotherapies. These players are focusing on developing innovative non-viral delivery platforms and gaining approval ...
... for their pipeline candidates.

The growing demand for targeted cancer therapies and personalized medicine is a major factor driving the demand for advanced non-viral delivery systems. These systems allow customized treatment approaches for different patient populations and cancer types.

Major pharmaceutical companies are also expanding their geographical presence and conducting clinical trials of non-viral drug carriers in different regions. This is expected to boost the global adoption of non-viral technologies over the coming years.

Market Drivers

One of the primary drivers fueling the non-viral drug delivery systems market is the growing need for safe and effective targeted therapy and personalized medicine. Traditional chemotherapy lacks specificity and causes damage to healthy cells. Non-viral carriers allow encapsulation of pharmaceutical actives and their controlled release at target sites in the body. This facilitates targeted delivery and enhances the efficacy of expensive biologics and gene therapeutics. The increased focus on developing personalized treatments for diseases like cancer is expected to promote the non-viral drug delivery systems market over the forecast period.

Impact Of Geopolitical Situation On The Growth Of Non-Viral Drug Delivery Systems Market

The ongoing geopolitical conflicts and tensions between major economies are negatively impacting the non-viral drug delivery systems market. Restrictions on exports and supply chain disruptions due to rising political instability and economic sanctions have hampered cross-border collaborations between pharmaceutical companies. This has stalled the development of innovative non-viral delivery technologies. Additionally, fluctuating currency exchange rates and rising inflationary pressures make long-term strategic planning difficult for market players. Furthermore, defense budget allocations have increased while funding for healthcare sectors has relatively reduced in many countries. This has constrained the resources available for R&D activities in advanced drug delivery areas. However, the outbreak of COVID pandemic across the globe increased focus on development of novel treatment and vaccination methods. It also highlighted the need for efficient non-invasive delivery systems. Going forward, market players must seek alternative sourcing, establish local manufacturing facilities and diversify their supply networks to minimize risks from geo-political issues. Forging public-private partnerships and expanding operations into politically stable markets can help sustain long-term growth even in uncertain scenarios.

Regions Where Non-Viral Drug Delivery Systems Market Is Concentrated In Terms Of Value:

North America represents the most lucrative regional market for non-viral drug delivery systems in terms of revenue. This can be attributed to the presence of well-established healthcare infrastructure and high patient affordability for advanced treatments in countries like the US and Canada. Additionally, substantial investments by both private and public players in cutting-edge research is providing a boost to the regional market. Europe holds the second largest revenue share owing to rising demand for efficient alternatives to viral vectors and supportive regulatory environment for clinical trials. Countries including Germany, UK and France have exhibited high adoption rates.

Fastest Growing Region For Non-Viral Drug Delivery Systems Market:

Asia Pacific region is projected to witness the highest growth during the forecast period attributed to rapidly increasing healthcare expenditures, sizable patient population and growing prevalence of chronic diseases. Emerging nations such as China, India and South Korea are aggressively focussing on development of domestic pharmaceutical capabilities including non-viral delivery technologies. This has created numerous business opportunities for international as well as local market participants. Furthermore, these countries provide favorable manufacturing and clinical trial costs which is expected to attract greater investments and drive higher market revenues over the coming years.

Get more insights on this topic:   https://fortunetelleroracle.com/health-fitness/the-non-viral-drug-delivery-systems-market-to-grow-owing-to-increasing-advantages-over-viral-delivery-methods-918137

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. (LinkedIn - https://www.linkedin.com/in/priya-pandey-8417a8173/)

What Are The Key Data Covered In This Non-Viral Drug Delivery Systems Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Non-Viral Drug Delivery Systems Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Non-Viral Drug Delivery Systems Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Non-Viral Drug Delivery Systems Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Non-Viral Drug Delivery Systems Market vendors

FAQ’s

Q.1 What are the main factors influencing the Non-Viral Drug Delivery Systems Market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Non-Viral Drug Delivery Systems Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Non-Viral Drug Delivery Systems Market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it